QUADRANT CAPITAL GROUP LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,381
+371.1%
3,590
+638.7%
0.00%
Q2 2023$2,416
-11.7%
486
-12.3%
0.00%
Q1 2023$2,737
+1111.1%
554
+1438.9%
0.00%
Q4 2022$226
-97.5%
36
-95.6%
0.00%
-100.0%
Q3 2022$9,0000.0%8260.0%0.00%0.0%
Q2 2022$9,000
-30.8%
826
-41.5%
0.00%
-50.0%
Q1 2022$13,000
+160.0%
1,413
+294.7%
0.00%
+100.0%
Q4 2021$5,000
+150.0%
358
+316.3%
0.00%
Q3 2021$2,00086
+975.0%
0.00%
Q2 2021$080.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders